… used to treating rheumatoid arthritis with Janus kinase (JAK) inhibitors and working in an
area (Lombardy, Italy) with a high incidence of coronavirus disease 2019 (COVID-19), we read …

… , we propose combining: (i) the development of efficient antivirals administered early …
anti-inflammatory treatments when needed, but not too early to interfere with endogenous antiviral …

… of drugs, focusing on patients moderately ill with COVID-19, and propose drug products,
including … Here, we present a strategy combining molecular docking vs with practical and clinical …

… pneumonia (COVID-19) patients treated with ruxolitinib in combination with … and anti-inflammatory
effects, the benefit in treating COVID-19 may be mainly attributed to its anti-viral effects…

… in COVID-19. Once, immunologic complications like cytokine storm occur… anti-viral treatment
alone is not enough and should be combined with appropriate anti-inflammatory treatment…

… COVID-19 clinical trials are testing combination therapies, with … combination pivotal
trials, of which approximately 60% are exploring drug classes such as antivirals and anti-inflammatory…

… Multifunctional AM-like NPs (termed TN@AM NPs) were successfully fabricated for combined
antiviral and anti-inflammatory treatments in a surrogate disease of COVID-19 caused by …

… drugs administered to patients with COVID-19, focusing on their antiviral, immune-modulatory
and/or anti-inflammatory … of the combination lopinavir/ritonavir in patients with COVID-19 is …

… for COVID-19 may be a three-step combination therapy, … stage of the disease, and combined
dexamethasone 6 mg/day plus … of anti-inflammatory and immune therapies in COVID-19: …

… Also, camostat mesylate, a direct TMPRSS2 inhibitor, is currently being investigated in
several clinical trials for COVID-19 as monotherapy or in combination with bicalutamide, with the …